Free Trial

Bausch Health Companies (TSE:BHC) Stock Price Up 0.9% - Should You Buy?

Bausch Health Companies logo with Medical background

Shares of Bausch Health Companies Inc. (TSE:BHC - Get Free Report) rose 0.9% on Thursday . The stock traded as high as C$8.97 and last traded at C$8.91. Approximately 218,073 shares changed hands during mid-day trading, a decline of 40% from the average daily volume of 361,495 shares. The stock had previously closed at C$8.83.

Bausch Health Companies Stock Performance

The firm has a 50 day moving average of C$7.68 and a two-hundred day moving average of C$8.69. The company has a debt-to-equity ratio of -1,831.94, a quick ratio of 0.58 and a current ratio of 1.19. The stock has a market cap of C$2.26 billion, a P/E ratio of -12.70, a P/E/G ratio of 0.21 and a beta of 0.77.

Insider Buying and Selling

In related news, Director John Paulson purchased 1,782,030 shares of Bausch Health Companies stock in a transaction dated Friday, June 13th. The shares were acquired at an average cost of C$8.14 per share, for a total transaction of C$14,501,803.73. In the last 90 days, insiders acquired 3,553,401 shares of company stock valued at $27,087,675. 11.28% of the stock is currently owned by company insiders.

About Bausch Health Companies

(Get Free Report)

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.

Featured Articles

Should You Invest $1,000 in Bausch Health Companies Right Now?

Before you consider Bausch Health Companies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bausch Health Companies wasn't on the list.

While Bausch Health Companies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines